Michael Wenger to Treatment Outcome
This is a "connection" page, showing publications Michael Wenger has written about Treatment Outcome.
Connection Strength
0.108
-
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS). Lancet Haematol. 2019 May; 6(5):e254-e265.
Score: 0.025
-
Consumption of Iron-Biofortified Beans Positively Affects Cognitive Performance in 18- to 27-Year-Old Rwandan Female College Students in an 18-Week Randomized Controlled Efficacy Trial. J Nutr. 2017 11; 147(11):2109-2117.
Score: 0.022
-
Double Fortified Salt Intervention Improved Iron Intake But Not Energy and Other Nutrient Intakes in Female Tea Plantation Workers From West Bengal, India. Food Nutr Bull. 2017 09; 38(3):369-383.
Score: 0.022
-
Efficacy of the repellent N,N-diethyl-3-methyl-benzamide (DEET) against tabanid flies on horses evaluated in a field test in Switzerland. Vet Parasitol. 2016 May 15; 221:64-7.
Score: 0.020
-
A Randomized Trial of Iron-Biofortified Pearl Millet in School Children in India. J Nutr. 2015 Jul; 145(7):1576-81.
Score: 0.019